ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Jan 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
February 2026
Nuclear Technology
January 2026
Fusion Science and Technology
November 2025
Latest News
Jeff Place on INPO’s strategy for industry growth
As executive vice president for industry strategy at the Institute of Nuclear Power Operations, Jeff Place leads INPO’s industry-facing work, engaging directly with chief nuclear officers.
Otohiko Aizawa, Keiji Kanda, Tetsuya Nozaki, Tetsuo Matsumoto
Nuclear Technology | Volume 48 | Number 2 | April 1980 | Pages 150-163
Technical Paper | Radiation | doi.org/10.13182/NT80-A32461
Articles are hosted by Taylor and Francis Online.
The remodeling of the neutron irradiation facility of the Musashi Institute of Technology Reactor (TRIGA Mark II, 100 kW) was carried out for the purpose of boron neutron capture therapy. The gamma contamination was reduced by the bismuth scatterer technique, and the thermal-neutron intensity was enlarged by virtue of the cavity effect. A 6LiF sheet was used instead of a 10B sheet for neutron collimation to minimize production of the secondary gamma rays. The characteristics of the optimized field are as follows: ɸth ≈ 1.3 × 1013 m-2· s-1 (1.3 × 109 n/cm2·s), gamma rays ≈ 1.8 × 10-6 O kg-1· s-1 (25 R/h), γ/n ≈ 0.5% in dose equivalent. When a phantom head was placed at the irradiation aperture, the neutron fluence rate (flux) and gamma-ray exposure rate increased to ∼2 × 1013 m-2 · s-1 (2 × 109 n/cm2 · s) and 1.1 × 10-5 C· kg-1 · s-1 (150 R/h), respectively, by the reflection of neutrons and capture gamma rays due to the phantom itself. The facility was licensed by the Japanese government to be used for the medical irradiation purposes on July 20, 1976.